Ipsen

Contact: Girish Aakalu
Email: girish.aakalu@ipsen.com
Website: https://www.ipsen.com/

Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in over 30 countries worldwide. Ipsen has more than 5,100 employees all over the world.

In Specialty Care, Ipsen is focused on three key therapeutic areas, Oncology, Neurosciences and Rare diseases, where Ipsen can establish a leadership position and leverage its expertise from drug development to commercialization. To complement the continued execution on its key products including the important launches of Cabometyx® and Onivyde®, Ipsen has defined a targeted and dynamic innovation model to accelerate Specialty Care growth.

Ipsen will continue to invest in business development through innovative deal structures with a focus on early to mid-stage assets in the three key therapeutic areas, targeting best-in-class, wholly-owned assets with global rights.

View Site